Procter & Gamble Hygiene and Health Care Ltd(PGHH)

NSE: PGHHBSE: 500459

₹ 6,850+0.67%refreshed 23 Oct, 03:30 pm ISTMarket cap: ₹ 22,236 crNext results: 12 Nov 2026Website: www.pg.com/en_INUpdated: 24 Oct 2026

About

Procter & Gamble Hygiene and Health Care makes and sells branded packaged FMCG products in feminine care and health care, under the Whisper, Vicks and Old Spice brands. It was incorporated as Richardson Hindustan Limited in 1964, and P&G acquired it in 1985. Its revenue for FY26 was Rs 4290.42 Cr. Its annual report calls Whisper India's leading feminine hygiene brand and Vicks India's No. 1 health care brand.^[1][2]

Business and market position

The company reports health and hygiene as a single segment, covering femcare and healthcare FMCG products.^[3][1]
Whisper held nearly half of the feminine care market in FY25. Category penetration was still below 50%.^[4]
The company held over half of the cough and cold market in FY25.^[4]

Brands and products

The Whisper range includes Bindazzz Nights, Choice, Choice Nights, Ultra and Period Panty. Bindazzz Nights and Choice Nights were strong growth drivers in FY26.^[1]
The Vicks range includes VapoRub, Cough Drops, Action 500 Advanced, ZzzQuil, Inhaler, Xtra Strong Rub, Baby Rub, VapoRub Steam Pods, Headache Roll-on and Cough Syrup.^[1]
Vicks Cough Syrup was launched as a premium, non-drowsy product, first sold only through e-commerce.^[1][4]
Vicks ZzzQuil Natura Sleep Gummies were upgraded with melatonin and ashwagandha in FY26.^[1]
Old Spice e-commerce business doubled in FY25, helped by creator-led social engagement.^[4]

Operations

As of FY26 the company has one manufacturing plant, in Goa, and its registered office is in Mumbai.^[1]
As of FY26 it has 23 offices in India, a count that includes depots, distribution centres and warehouses.^[1]
Total workers numbered 471 at the end of FY26.^[1]

Key operating numbers

Productivity savings were INR 86 crore in FY26, compared with INR 93 crore in FY25.^[5][6]
Sales in FY26 were flat and PAT grew 19%, compared with April 2024 to March 2025.^[5]
Net margin rose about 60bps in FY25 despite mid-single-digit cost inflation.^[4]

Customers and distribution

Products are sold in 28 states and 8 union territories of India.^[1]
Sales channels include distributors, modern retail, canteen stores, pharmacies and e-commerce platforms.^[1]
Distribution coverage grew by 1 million stores over the three years to FY25.^[4]
The company exported products to 14 countries in FY2025-26.^[1]
The company describes its customer base as large and unrelated.^[1]
In FY25, rural demand was recovering while urban consumption stayed under pressure.^[4]

Initiatives

In FY26 the company was investing in a core data lake, an AI factory, operational data and consumer research.^[5]
Other initiatives include AI/ML-based assortment chosen store by store, a Supply 3.0 programme for continuous ordering, and co-creating products with quick-commerce partners.^[6]
Capital commitments of 1,070 lakh were outstanding as of FY25.^[3]

Recent changes

The fiscal year moved to April-March, so FY25 was a 9-month period. Sales were Rs 3374 cr, up 3%, and PAT was Rs 636 cr, up 7%.^[4]

Market Cap

₹22,236 Cr

High / Low

₹14,244 / 6,576

Stock P/E

29.6

Price / Book

31.1

Book Value

₹232

EPS

₹263.9

No. of Shares

3.25 Cr

ROCE

157.8%

ROE

114.9%

OPM

27.1%

Debt / Equity

0.00

Sales

₹4,290 Cr

Net Profit

₹857 Cr

Promoter holding

70.6%

Loading chart…

Signal history

AI Deep Dive

The analysis Screener can't give you

Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:

Verdict
The headline call - descriptive label, conviction, and the synthesis behind it.
Valuation
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Walk the talk
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Red flags
Forensic and governance risk pointers, severity-ranked.
Balance sheet
Solvency and earnings-quality score.
Concall briefs
Quarter-by-quarter earnings-call briefs - what changed and why.

₹49 unlocks this company for 90 days, ₹299 for a full year - bundles bring it lower. Built on public disclosures - educational, not investment advice.

AI Deep Dive

Verdict

Locked

The headline call - descriptive label, conviction, and the synthesis behind it.

Company data

Financials